切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (12) : 1002 -1008. doi: 10.3877/cma.j.issn.1674-0785.2020.12.010

所属专题: 文献

综述

神经干细胞在精神分裂症患者治疗中的研究进展
王天仁1, 张巧霞1, 石瑶1, 汤雯珺1, 马捷2,()   
  1. 1. 710061 西安,西安交通大学环境与疾病相关基因教育部重点实验室
    2. 710061 西安,西安交通大学环境与疾病相关基因教育部重点实验室;710018 西安,西安市第三医院医学研究中心
  • 收稿日期:2020-06-29 出版日期:2020-12-15
  • 通信作者: 马捷
  • 基金资助:
    国家自然科学基金项目(31371298); 大学生创新性实验项目(GJ201910698157); 中华医学会医学教育分会和中国高等教育学会医学教育专业委员会2018年医学教育研究立项课题(2018B-N02199)

Advances in neural stem cells in the treatment of patients with schizophrenia

Tianren Wang1, Qiaoxia Zhang1, Yao Shi1, Wenjun Tang1, Jie Ma2,()   

  1. 1. Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China
    2. Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China; Medical Research Center, Xi'an No.3 Hospital, Xi'an 710018, China
  • Received:2020-06-29 Published:2020-12-15
  • Corresponding author: Jie Ma
引用本文:

王天仁, 张巧霞, 石瑶, 汤雯珺, 马捷. 神经干细胞在精神分裂症患者治疗中的研究进展[J]. 中华临床医师杂志(电子版), 2020, 14(12): 1002-1008.

Tianren Wang, Qiaoxia Zhang, Yao Shi, Wenjun Tang, Jie Ma. Advances in neural stem cells in the treatment of patients with schizophrenia[J]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(12): 1002-1008.

精神分裂症作为一种慢性、致残率高的精神疾病,存在多巴胺假说、失连接假说、神经发育障碍假说、氧化应激假说等多种假说解释其发病机制。神经干细胞具有分裂分化的潜能和修复中枢损伤的作用,在中枢神经系统多个脑区广泛分布。相关研究表明,精神分裂症与胚胎神经干细胞异常和神经发生有关。目前药物治理是精神疾病的主要临床治疗手段,但不可避免地存在多种弊端。根据多巴胺假说,腹侧海马在精神分裂症的治疗中处在关键地位,是各个假说的“共同通路”。借助诱导性多能干细胞建立精神分裂症疾病模型,对疾病发病机制的研究陆续取得进展。神经干细胞在胚胎发育和神经系统发生损伤时的修复过程中发挥着重要作用,将其用于精神分裂症的治疗具有显著优势,这为精神分裂症的治疗提供了新的思路。

Schizophrenia is a chronic mental disease with a high disability rate. Several hypotheses, including dopamine hypothesis, disconnection hypothesis, neurodevelopmental disorder hypothesis, and oxidative stress hypothesis, have been proposed to explain its pathogenesis. Neural stem cells have the potential of differentiation and repair of central damage and are widely distributed in multiple brain regions of the central nervous system. Related studies have shown that schizophrenia is related to the abnormality of embryonic neural stem cells and neurogenesis. The early development of the brain is susceptible to interference from multiple genes and environments, and most people with schizophrenia have more psychotic symptoms than those that they had in late adolescence or early adulthood. Antipsychotic medications are the main clinical treatment for mental illness, but they inevitably have some drawbacks. According to the dopamine hypothesis, the ventral hippocampus plays a key role in the treatment of schizophrenia, acting as a "common pathway" for each hypothesis. With the help of induced pluripotent stem cells, the schizophrenia disease model has been established, and the research on its pathogenesis has made progress. Neural stem cells play an important role in embryonic development and repair of the damaged nervous system, and they have a significant advantage over traditional treatment methods in the treatment of schizophrenia, which provides a new idea for the treatment of schizophrenia.

1
Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016 [J]. Schizophr Bull, 2018, 44(6): 1195-1203.
2
Akter M, Kaneko N, Sawamoto K. Neurogenesis and neuronal migration in the postnatal ventricular-subventricular zone: similarities and dissimilarities between rodents and primates [J]. Neurosci Res, 2020, 6(3): 549-562.
3
Kim CW, Lee SM, Ko EB, et al. Inhibitory effects of cigarette smoke extracts on neural differentiation of mouse embryonic stem cells [J]. Reprod Toxicol, 2020, 10(1): 75-85.
4
Henzi R, Vio K, Jara C, et al. Neural stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model [J]. Cell Tissue Res, 2020, 381(10): 141-161.
5
张勇辉, 王永军, 邹琳, 等. 精神分裂症神经发育障碍假说的研究进展 [J]. 四川精神卫生, 2014, 27(4): 2-5.
6
Shin JE, Lee H, Jung K, et al. Cellular response of ventricular-subventricular neural progenitor/stem cells to neonatal hypoxic-ischemic brain injury and their enhanced neurogenesis [J]. Yonsei Med J, 2020, 61(6): 492-505.
7
Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view [J]. Antioxid Redox Signal, 2011, 15(7): 2011-2035.
8
Ohtani T, Levitt JJ, Nestor PG, et al. Prefrontal cortex volume deficit in schizophrenia: a new look using 3T MRI with manual parcellation [J]. Schizophr Res, 2014, 152(1): 184-190.
9
杨坦, 刘华, 汪运山. 2种诱导iPSC向神经干细胞分化方法的比较 [J]. 中国病理生理杂志, 2015, 31(1): 188-192.
10
Iannitelli A, Quartini A, Tirassa P, et al. Schizophrenia and neurogenesis: a stem cell approach [J]. Neurosci Biobehav Rev, 2017, 80: 414-442.
11
Petrides G, Malur C, Braga RJ, et al. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study [J]. Am J Psychiat, 2015, 172(1): 52-58.
12
徐德毅, 李琴繁, 易军, 等. 精神分裂症患者DRD1-48A /G基因多态性与工作记忆能力的关系分析 [J]. 疑难病杂志, 2016, 15(12): 1271-1274.
13
盛飞凤, 廖炽泉, 王康梅, 等. 多巴胺D1受体基因多态性对氯氮平片治疗精神分裂症疗效的影响 [J]. 中国临床药理学杂志, 2019, 35(11): 1128-1131.
14
刘洋, 李敏, 侯悦, 等. 精神分裂症的药物治疗选择: 第一代与第二代抗精神病药比较 [J/OL]. 中华临床医师杂志(电子版),2012, 6(12) : 3374-3376.
15
阿米娜·热合木吐拉, 热沙来提·阿不都拉. 典型和非典型抗精神病药物联合治疗精神分裂症患者的不良反应的分析 [J]. 心理月刊, 2019, 14(14): 163.
16
Lodge DJ, Grace AA. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia [J]. Trends Pharmacol Sci, 2011, 32(9): 507-513.
17
Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat [J]. J Neurosci, 2000, 20(11): 4320-4324.
18
Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction [J]. Nature, 2011, 477(7363): 171-178.
19
Donegan JJ, Tyson JA, Branch SY, et al. Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model [J]. Mol Psychiatry, 2017, 22(10): 1492-1501.
20
Tyson JA, Goldberg EM, Maroof AM, et al. Duration of culture and sonic hedgehog signaling differentially specify PV versus SST cortical interneuron fates from embryonic stem cells [J]. Development, 2015, 142(7): 1267-1278.
21
Nichols K, Koppes R, Koppes A. Recent advancements in microphysiological systems for neural development and disease [J]. Curr Opin Biomed Eng, 2020, 5(3): 145-147.
22
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell, 2006, 126(4): 663-676.
23
Noh H, Shao ZC, Coyle JT, et al. Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs) [J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(9): 2382-2387.
24
Watmuff B, Berkovitch SS, Huang, JH, et al. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells [J]. Mol Cell Neurosci, 2016, 73: 96-103.
25
Kim S, Kim MK, Oh D, et al. Induced pluripotent stem cells as a novel tool in psychiatric research [J]. Psychiatry Investig, 2016, 13(1): 8-17.
26
Wen ZX, Nguyen HN, Guo ZY, et al. Synaptic dysregulation in a human iPS cell model of mental disorders [J]. Nature, 2014, 515(7527): 414-418.
27
Robicsek O, Karry R, Petit I, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients [J]. Mol Psychiatry, 2013, 18(10): 1067-1076.
28
Wright R, Rethelyi JM, Gage FH. Enhancing induced pluripotent stem cell models of schizophrenia [J]. JAMA Psychiatry, 2014, 71(3): 334-335.
29
任佩佩, 樊晋宇, 郭鑫鑫, 等. 用精神分裂症患者皮肤成纤维细胞构建诱导性多潜能干细胞模型 [J]. 新乡医学院学报, 2016, 33(7): 572-576.
[1] 周伟, 蔡恒, 范海迪, 李惠中, 王传霞, 顾茂胜. cblC型甲基丙二酸血症MMACHC基因新突变对小鼠神经细胞凋亡及Wnt/β-catenin信号通路的作用机制[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 528-539.
[2] 刘伟华, 赵宇, 刘仲凤, 吴焕童, 张广吉, 陈志国. 神经干细胞生物制剂治疗中枢神经系统恶性肿瘤的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(01): 59-62.
[3] 徐如祥, 邱文乔. 生物组装类脑生态位促进神经再生修复展望[J]. 中华神经创伤外科电子杂志, 2022, 08(01): 1-5.
[4] 王洋洋, 高谋, 徐如祥. 过敏毒素、小胶质以及神经干细胞在神经炎症和神经再生中的作用[J]. 中华神经创伤外科电子杂志, 2021, 07(04): 193-198.
[5] 喻勇, 杨华, 徐卡娅. 胎儿脊柱裂的致病因素与治疗的研究进展[J]. 中华神经创伤外科电子杂志, 2021, 07(03): 187-190.
[6] 高谋, 徐如祥, 董勤, 郭莉丽. CR2-Crry预处理诱导神经干细胞在颅脑损伤中发挥神经保护作用[J]. 中华脑科疾病与康复杂志(电子版), 2021, 11(04): 215-220.
[7] 尹营营, 袁勇贵. 抑郁症精神运动迟滞的评估方法及生物学机制研究[J]. 中华临床医师杂志(电子版), 2022, 16(08): 712-718.
[8] 周庆忠, 冯晓兰, 何萍, 张戈, 赵茂, 白永恒, 冯大雄. 封闭Notch信号影响神经干细胞分化的体外研究[J]. 中华临床医师杂志(电子版), 2022, 16(06): 579-587.
[9] 殷秀梅, 杨丽红, 姜涛, 杜元灏. 基于神经干细胞探讨巢蛋白在缺血性脑卒中中的作用机制及针刺效应[J]. 中华针灸电子杂志, 2023, 12(03): 111-116.
[10] 姚珍珍, 陈昂昂, 周亚楠, 赵高峰, 张申帅, 翟金国, 陈敏. 精神分裂症认知功能损害的特点、机制及干预方式研究进展[J]. 中华诊断学电子杂志, 2023, 11(01): 28-32.
[11] 孙振晓, 刘化学, 任德菊. 烦渴-间歇性低钠血症-精神病综合征诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2022, 10(04): 266-269.
[12] 林玮怡, 林慧, 陈建仁, 肖龙, 岑修记, 黄登强. 精神分裂症患者病情与超敏C反应蛋白水平变化关系[J]. 中华诊断学电子杂志, 2022, 10(02): 119-122.
[13] 李俏俊, 吕兴平, 徐佳圆, 禚传君. 多基因风险分数在精神分裂症预防与预测中的应用与挑战[J]. 中华诊断学电子杂志, 2021, 09(03): 149-151.
[14] 姜荣涛, 戚世乐, 吴静, 李想, 赵敏, 隋婧, 禚传君. 基于多模态脑影像和机器学习算法的个体行为预测研究现状及未来趋势[J]. 中华诊断学电子杂志, 2021, 09(03): 145-148.
[15] 马晓瑭, 王艳, 李素青, 刘金花, 石雨萌, 潘群文. 富含miR-132-3p的神经干细胞释放的外泌体激活MEK1/2/-ERK1/2通路改善缺氧无糖诱导的脑微血管内皮细胞损伤[J]. 中华脑血管病杂志(电子版), 2022, 16(03): 172-181.
阅读次数
全文


摘要